Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pedicare is a professional foot care product line developed and marketed by the Swedish pharmaceutical company Evolan Pharma. The series is designed for both clinical podiatry and consumer use, targeting common foot conditions such as xerosis (dry skin), hyperkeratosis (calluses), and cracked heels. The formulations typically feature urea (carbamide) as a key active ingredient, which functions as a humectant to increase skin hydration and as a keratolytic agent to soften and remove thickened skin. The Pedicare range includes a variety of topical products, including intensive moisturizing creams, foot baths, and specialized medical device treatments for fungal nail infections and warts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pedicare.